108 related articles for article (PubMed ID: 529958)
1. [Tumor associated antigens induce humoral and cellular immune response to laryngeal carcinomas (author's transl)].
Zenner HP; Herrmann IF
Laryngol Rhinol Otol (Stuttg); 1979 Nov; 58(11):865-70. PubMed ID: 529958
[TBL] [Abstract][Full Text] [Related]
2. [Serologic analysis of tumor antibodies in the sera of patients with carcinoma of the larynx (author's transl)].
Blume N; Milatovic D
Laryngol Rhinol Otol (Stuttg); 1981 Aug; 60(8):405-6. PubMed ID: 7346674
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibodies against surface antigens of cancer cells. Experimental preparation for early diagnosis and immuno-assisted therapy].
Zenner HP
Fortschr Med; 1983 May; 101(19):891-2, 894. PubMed ID: 6873841
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibodies against surface antigens of laryngeal carcinoma cells (author's transl)].
Zenner HP
Arch Otorhinolaryngol; 1981; 233(2):161-72. PubMed ID: 6172103
[TBL] [Abstract][Full Text] [Related]
5. [Does an immune reactivity to human laryngeal cancer exist?].
Cortesina G; Cavallo GP; Sartoris A; Beatrice F; Morra B; Bussi M; Poggio E
G Batteriol Virol Immunol; 1979; 72(1-6):169-90. PubMed ID: 399929
[TBL] [Abstract][Full Text] [Related]
6. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
Kan-Mitchell J; White WL; Mitchell MS
Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881
[TBL] [Abstract][Full Text] [Related]
7. Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells.
Savage HE; Rossen RD; Hersh EM; Freedman RS; Bowen JM; Plager C
Cancer Res; 1986 Apr; 46(4 Pt 2):2127-33. PubMed ID: 3948184
[TBL] [Abstract][Full Text] [Related]
8. Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course.
Mizukami M; Hanagiri T; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Yasuda M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2005 Dec; 96(12):882-8. PubMed ID: 16367908
[TBL] [Abstract][Full Text] [Related]
9. [Production and preclinical use of a monoclonal immunotoxin against laryngeal cancer cells].
Zenner HP
Laryngol Rhinol Otol (Stuttg); 1984 Nov; 63(11):566-9. PubMed ID: 6521585
[TBL] [Abstract][Full Text] [Related]
10. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials.
Hollinshead AC
Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778
[TBL] [Abstract][Full Text] [Related]
11. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)].
Niksić M; Balogh M
Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570
[TBL] [Abstract][Full Text] [Related]
12. Surface antigens of BK virus-induced tumor cells.
Karjalainen HE
Med Biol; 1981 Feb; 59(1):35-40. PubMed ID: 6267387
[TBL] [Abstract][Full Text] [Related]
13. Cis-diamminedichloroplatinum(II) augments expression of tumor-associated antigens on human gastric cancer cell line KATO-3 and increases susceptibility and binding of tumor cells to various cytotoxic effector cells.
Hayashi H; Nio Y; Kawabata K; Araya S; Imamura M
J Surg Oncol; 1996 Jul; 62(3):162-70. PubMed ID: 8667622
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H
J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
Mang WL; Hammer C
J Med; 1981; 12(6):447-53. PubMed ID: 7033427
[TBL] [Abstract][Full Text] [Related]
16. Fate of HL-A antigens and antibodies at the lymphocyte surface.
Cullen SE; Bernoco D; Carbonara AO; Jacot-Guillarmod H; Trinchieri G; Ceppellini R
Transplant Proc; 1973 Dec; 5(4):1835-47. PubMed ID: 4130085
[No Abstract] [Full Text] [Related]
17. [Tumor specific surface antigens and immunological reaction of Rous sarcoma (review) (author's transl)].
Hayami M
Uirusu; 1981 Jun; 31(1):1-20. PubMed ID: 6277085
[No Abstract] [Full Text] [Related]
18. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
[TBL] [Abstract][Full Text] [Related]
19. Oncornavirus directed tumor cell surface antigens detectable by humoral and cellular immunity.
Bauer H; Kurth R; Gelderblom H
Johns Hopkins Med J Suppl; 1974; 3():445-54. PubMed ID: 4371550
[No Abstract] [Full Text] [Related]
20. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
